This registration is now closed. Walk-ins welcome.
This conference is a comprehensive review of hematologic malignancies focusing on the clinical application of new research developments over the preceding year. Didactic presentations will include case discussions with Penn faculty and community experts.
The conference format will provide significant opportunity for interaction with expert faculty and other attendees. Participants will leave with up-to-date, practical information which will have immediate clinical application.
This activity has been designed for hematologists, medical and radiation oncologists, primary care physicians, pathologists, hematology/oncology fellows, oncology nurses, oncology social workers, and other healthcare professionals involved in the treatment of patients with blood cancers.
Upon completion of this conference, participants should be able to:
- Discuss clinical features, including differential diagnoses for the various hematologic malignancies
- Describe recent advances in treatment for the various hematologic malignancies
- Summarize the major patient management issues experienced by the interprofessional care team associated with hematologic malignancies
- Define the state-of-the-art for genomic analyses for hematologic malignancies
- Apply new strategies for incorporating therapies that target metabolism in blood cancers
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Of Credit
- PHYSICIANS: Penn Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- NURSES: The program will award 8.25 contact hours.
- PHYSICIAN ASSISTANTS: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 8.25 Category 1 credits for completing this activity.
The Perelman School of Medicine at the University of Pennsylvania, Office of Continuing Medical Education, adheres to the ACCME Standards for Commercial Support. Faculty disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and / or investigational use of pharmaceutical products or devices with in their presentations.